O. H. Y. Yu

First name
O.
Last name
H. Y. Yu
Lix, L. M., Sobhan, S., St-Jean, A., Daigle, J. M., Fisher, A., H. Y. Yu, O., et al. (2021). Validity of an algorithm to identify cardiovascular deaths from administrative health records: a multi-database population-based cohort study. BMC Health Serv Res. http://doi.org/10.1186/s12913-021-06762-0
Yu, Y. H., Filion, K. B., Reynier, P., Platt, R. W., H. Y. Yu, O., & Grandi, S. M. (2021). Use of levothyroxine among pregnant women with subclinical hypothyroidism in the United Kingdom: A population-based assessment. Pharmacol Res Perspect. http://doi.org/10.1002/prp2.848
Brunetti, V. C., Reynier, P., Azoulay, L., H. Y. Yu, O., Ernst, P., Platt, R. W., & Filion, K. B. (2021). SGLT-2 inhibitors and the risk of hospitalization for community-acquired pneumonia: A population-based cohort study. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5192
Brunetti, V. C., H. Y. Yu, O., Platt, R. W., & Filion, K. B. (2021). Initiation of four basal insulins and subsequent treatment modification in people treated for type 2 diabetes in the United Kingdom: Changes over the period 2003-2018. Diabet Med. http://doi.org/10.1111/dme.14603
Faillie, J. L., Yin, H., H. Y. Yu, O., Herrero, A., Altwegg, R., Renoux, C., & Azoulay, L. (2021). Incretin-Based Drugs and Risk of Intestinal Obstruction Among Patients with Type 2 Diabetes. Clin Pharmacol Ther. http://doi.org/10.1002/cpt.2430
Pradhan, R., Abrahami, D., Yin, H., H. Y. Yu, O., Sahasrabudhe, V., Andre, B., & Azoulay, L. (2021). Defining Clinically-Relevant Target Populations Using Real-World Data to Guide the Design of Representative Antidiabetic Drug Trials. Clin Pharmacol Ther. http://doi.org/10.1002/cpt.2213